Evidence map›Paper›PMID 30196430›Full record

ArticleBrain structure & function2018

Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity.

Kelsey M Greathouse, Benjamin D Boros, Josue F Deslauriers, Benjamin W Henderson, Kendall A Curtis, Erik G Gentry, Jeremy H Herskowitz

Abstract read
In one paragraph

Article in Brain structure & function, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kelsey M GreathouseDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Benjamin D BorosDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Josue F DeslauriersDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Benjamin W HendersonDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Kendall A CurtisDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Erik G GentryDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA.
Jeremy H HerskowitzDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL, 35294, USA. jhersko@uab.edu.ORCID http://orcid.org/0000-0002-7227-1470
University of Alabama at Birmingham · US

Funding

Identifying therapeutic targets that confer synaptic resilience to Alzheimer's diseaseR01AG061800 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Christopher A. Gaiteri, Jeremy H. Herskowitz · 2018 to 2026
$6.9M
UAB Research Training Program in Neurobiology of Cognition and Cognitive DisordersT32NS061788 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Farah Dominique Lubin · 2008 to 2026
$4.5M
Targeting Rho Kinases for Alzheimer's disease TherapeuticsR01AG054719 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HERSKOWITZ, JEREMY H. · 2017 to 2021
$1.9M
Investigating the RhoA/ROCK pathway for the treatment of Alzheimer's diseaseR00AG043552 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HERSKOWITZ, JEREMY H. · 2014 to 2016
$740k
Investigating the RhoA/ROCK pathway for the treatment of Alzheimer's diseaseK99AG043552 · NIA · EMORY UNIVERSITY · PI HERSKOWITZ, JEREMY H. · 2012 to 2013
$174k
Alzheimer's Association NIRG-339422NIA NIH HHS AG043552-05NIA NIH HHS AG054719NIA NIH HHS AG061800NIA NIH HHS K99 AG043552NIA NIH HHS R00 AG043552NIA NIH HHS R01 AG054719NINDS NIH HHS T32 NS061788
6 · The paper itself

Abstract

Rho-associated protein kinases (ROCK) 1 and 2 are attractive drug targets for a range of neurologic disorders; however, a critical barrier to ROCK-based therapeutics is ambiguity over whether there are isoform-specific roles for ROCKs in neuronal structural plasticity. Here, we used a genetics approach to address this long-standing question by analyzing both male and female adult ROCK1

Indexed as

Neuronal PlasticityAnimalsDendritic SpinesFemaleImaging, Three-DimensionalMaleMice, TransgenicNeuronsPrefrontal CortexProtein Isoformsrho-Associated KinasesProtein Isoformsrho-Associated KinasesRock1 protein, mouseRock2 protein, mouseDendritic arborDendritic spinesLIM kinaseMorphometryPrefrontal cortexRho kinaseSynaptosomes

Identifiers

PMID30196430
PMCPMC6252131
OpenAlexW2889832137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.